TOKYO - Reports of ill health after consumption of Kobayashi Pharmaceutical Co.'s red yeast rice dietary supplements implicated in two deaths largely relate to products made since September last year, the health ministry said Wednesday.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
